Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO)
Journal of Blood Medicine · 2026-01 · Volume 17 · 1-15
DOI: 10.2147/jbm.s570135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Blood Medicine, 2026-01. Verfasst von Huiling Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chin…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by bleeding, yet paradoxically, it can also predispose patients to thrombotic events; therefore, investigating high-risk factors for thrombosis in ITP patients and developing a predictive model is essential. Patients and Methods: A total of 1112 patients were diagnosed with ITP between January 2018 and December 2023. Excluding 216 patients under the age of 18, a total of 896 adult ITP patients were included in this study (of whom 101 developed thrombosis). Patients were randomly allocated to the training set (n=628) and validation set (n=268) in a 7:3 ratio.
Results
Atrial fibrillation, peripheral vascular disease, venous thromboembolism history, pneumonia < 1 month, cerebrovascular events history, and D-dimer levels were identified as predictive factors for thrombosis in ITP patients. The six factors formed 57 unique combinations, providing robust predictive power for thrombosis in ITP under different clinical scenarios. In the training set, the area under the curve (AUC) for the nomogram was 0.656 (95% CI: 0.578-0.735) to 0.931 (95% CI: 0.902-0.960) and the AUC in the validation set was 0.539 (95% CI: 0.425-0.653) to 0.893 (95% CI: 0.828-0.957). The calibration curve demonstrated good concordance between the model's predicted probabilities and actual observed probabilities, and the decision curve analysis indicated that the model had significant clinical utility.
Conclusion
This cohort study developed a simple and practical predictive model (ITP-THROMBO) for estimating thrombosis risk in ITP patients; this model facilitates rapid identification of ITP patients at high thrombotic risk, enabling timely decision-making support for personalized treatment planning.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
- Department of Hematology, Anhui Provincial Hospital, WanNan Medical College, Wuhu, People's Republic of China.
- Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
ORCID-Profile: Juan Tong, Changcheng Zheng
Zitieren
APA
Yan, H., Hu, X., Zhu, L., Jiang, Y., Luo, C., Lv, M., Wang, Y., Tong, J., & Zheng, C. (2026). Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO). Journal of Blood Medicine, Volume 17, 1-15. https://doi.org/10.2147/jbm.s570135
Vancouver
Yan H, Hu X, Zhu L, Jiang Y, Luo C, Lv M, et al. Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO). Journal of Blood Medicine. 2026;Volume 17:1-15. doi:10.2147/jbm.s570135
BibTeX
@article{Yan2026,
author = {Yan, Huiling and Hu, Xing and Zhu, Lijun and Jiang, Yuhan and Luo, Chen and Lv, Mengya and Wang, Yan and Tong, Juan and Zheng, Changcheng},
title = {Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO)},
journal = {Journal of Blood Medicine},
year = {2026},
volume = {Volume 17},
pages = {1--15},
doi = {10.2147/jbm.s570135}
}
EUVIMED